Full Length Research Paper
References
|
Adoubi KA, Nguetta R, Yangni-Angate KH, Diby KF, Adoh AM (2006). Epidemiological, clinical and therapeutic aspects of hypertension in Bouaké. Cahier de Santé Publique 5(2):28-35. |
|
|
Alina D, Ciprian J, Laurent A (2021). Hydroxychloroquine in systemic and autoimmune diseases: where do we stand? Revue du Rhumatisme 88(5):346-353. |
|
|
Bamba-Kamagate D, Coulibaly I, Soya E, Traore F, N'cho-Mattoh MP, Koffi F, Tanoh M (2016). Drug prescription analysis at hospital Discharge for Heart Failure Patient at the Institute of Cardiologie of Abidjan. World Journal of Cardiovascular Diseases 6(3):73-79. |
|
|
Bhagteshwar S, Hannah R, Tamara C, Marty C, Tom F (2021). Chloroquine or hydroxychloroquine for prevention and treatment of COVID?19. Cochrane Database of Systematic Reviews 2021(2):CD013587. |
|
|
Coulibaly S, Diakité S, Diallo IB, Menta I, Sacko AK, Diallo B (2010). Cerebrovascular accidents: risk factors, evolution and prognosis in the cardiology department "B" of the Point G University Hospital, Bamako. Mali Medical 25(1):32-36. |
|
|
Cowppli-bony P, Sonan- Douayoua T, Akani F, Ahogo C, N'guessan K, Beugre EK (2007). Epidemiology of cerebrovascular accidents in the neurology department of Bouake. Médecine d'Afrique Noire 54(4):199-202. |
|
|
National Institute of Statistics (NIS) (2014). General Census of Population and Housing. Available on ABIDJANTV.NET. Accessed on 03/02/2018 |
|
|
International Society of Drug Bulletins (ISDB) (2005). Berlin Declaration on Pharmacovigilance. La Revue Prescrire 25(260):276- 310 |
|
|
Kamagate M, Yavo JC, Die-Kakou HM (2016). Diagnosis of pharmacovigilance difficulties by health professionals in Côte d'Ivoire. Asian Journal of Pharmaceutical Research 6(1):32-36. |
|
|
Katchunga PB, M'Buyamba-Kayamba J-R, Masumbuko BE, Lemogoum D, Kashongwe ZM, Degaute JP, Kabinda JM, M'Buyamba-Kabangu J-R (2011). Hypertension in Congolese adults in South Kivu: results of the Vitaraa study. Presse Médicale 40(6):e315-323. |
|
|
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, Jiang H (2005). Global burden of hypertension: analysis of worldwide data. Lancet 365(9455):217-223. |
|
|
Konin C, Adoh M, Coulibaly I, Kramoh E, Safou M, N'guetta R, N'Djessan JJ, Koffi J (2007). Therapeutic compliance and its factors in black African hypertensive patients with ACI. Archives des Maladies du Cœur et des Vaisseaux 100(8):630-634. |
|
|
Landry Y, Rival Y (2007). Pharmaceutical dictionary-pharmacology and chemistry of drugs. France: TEC ET DOC/INTER/LAVOISIER |
|
|
Millogo GRC, Zongo RFE, Benao A, Youl ENH, Bassoleth BAB, Ouedraogo M, Zabsonré P, Guissou IP (2018). Prevalence and characteristics of adverse reactions to antihypertensive drugs in patients followed as outpatients at the Centre Hospitalier Universitaire Yalgado Ouédraogo. Pan African Medical Journal 29:84. |
|
|
Nessaibia I, Tichati L, Bouarroudj T, Siciliano D, Bouslama Z, Merad T, Tahraoui A (2021). Mechanisms possibly involved in the antiviral effects of chloroquine and hydroxychloroquine - What reality for the treatment of COVID-19? Toxicologie Analytique and Clinique 369:11. |
|
|
N'goran YNK, Traore F, Tano M, Kramoh KE, Anzouan KJB, Konin C, Guikahue MK (2015). Epidemiological aspects of cerebrovascular accidents (strokes) in the emergency department of the Abidjan Cardiology Institute (ACI). Pan African Medical Journal 21:160. |
|
|
Olivier P, Boulbès 0, Tubery M, Caries P, Montastruc JL, Lapeyre-Mestre M (2001). Avoidability of adverse drug reactions in a medical admissions department. Thérapie 56(3):275-278. |
|
|
Olowofela AO, Isah AO (2017). A profile of adverse effects of antihypertensive medicines in a tertiary care clinic in Nigeria. Annals of African Medicine 16(3):114-119. |
|
|
Ruscin JM, Sunny AL (2021). Medication-related problems in the elderly. Geriatrics-Professional Edition of the MSD Manual. United States: Merck & Co |
|
|
Sagui E (2007). Strokes in sub-Saharan Africa. Médecine Tropicale 67(6):596-600. |
|
|
Snezana M, Zoran B, Aleksandra K, Aneta B, Dragana P, Zoran T (2015). Adverse drug reactions in hospitalized cardiac patients: characteristics and risk factors. Vojnosanitetski Pregled 72(11):975-981. . |
|
|
Trinh-Duc A, Doucet J, Bannwarth B, Trombert-Paviot B, Carpentier F, Bouget J, Queneau P (2007). Admissions of elderly patients to emergency departments for adverse drug reactions. Thérapie 62(5):437-441. |
|
|
Veyrac G, Jolliet P (2006). Urticaria medicamentosa and imputability. Revue Française d'Allergologie et d'Immunologie Clinique 46:283-287. |
|
|
Yobo-Bi MS, Toure M, Kee MYC, N'zoué KS, Diallo CO, Kpea DL, Kamagaté M (2020). Incidence of adverse events in ambulatory treatments at the Abidjan Cardiology Institute (ACI). Ivoire Pharmacologie 1:23-31 |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
